At a time when colorectal cancer is on the rise, a new study finds the disease can be detected through a blood test.
The results of a clinical trial, published Wednesday, in The New England Journal of Medicine, show that the blood-based screening test detects 83% of people with colorectal cancer. If the FDA approves it, the blood test would be another screening tool to detect the cancer at an early stage.
The test, developed by Guardant Health, can be done from a blood draw. The company says its test detects cancer signals in the bloodstream by identifying circulating tumor DNA.
Nearly half of all pregnancies worldwide are unplanned. And despite the many birth control options for...
The Supreme Court on Monday allowed Idaho to begin enforcing a state law barring transgender youth...
Treating gunshot wounds on children was not what Mikael Petrosyan expected when he entered pediatrics.
Petrosyan has...
